🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/01/2009 | 34,15 | 34,31 | 33,70 | 33,98 | +0,18% | 1,79% | 681.400 |
| 29/01/2009 | 33,70 | 34,40 | 33,39 | 33,92 | -0,21% | 3,01% | 806.800 |
| 28/01/2009 | 33,41 | 34,17 | 33,11 | 33,99 | +2,50% | 3,19% | 629.200 |
| 27/01/2009 | 32,78 | 33,59 | 32,78 | 33,16 | +1,50% | 2,47% | 443.600 |
| 26/01/2009 | 32,56 | 33,25 | 32,43 | 32,67 | +0,96% | 2,53% | 672.400 |
| 23/01/2009 | 31,69 | 32,99 | 31,30 | 32,36 | +1,27% | 5,33% | 885.800 |
| 22/01/2009 | 31,53 | 32,53 | 31,50 | 31,95 | +1,04% | 3,25% | 1.018.400 |
| 21/01/2009 | 31,18 | 31,89 | 30,71 | 31,62 | +2,00% | 3,79% | 1.043.000 |
| 20/01/2009 | 31,23 | 31,50 | 30,87 | 31,00 | -1,18% | 2,02% | 1.176.600 |
| 16/01/2009 | 31,65 | 31,65 | 30,50 | 31,37 | -0,71% | 3,62% | 798.200 |
| 15/01/2009 | 30,42 | 31,63 | 29,94 | 31,60 | +3,76% | 5,54% | 919.000 |
| 14/01/2009 | 31,19 | 31,50 | 30,10 | 30,45 | -3,21% | 4,50% | 1.290.600 |
| 13/01/2009 | 31,41 | 32,31 | 30,93 | 31,46 | +0,87% | 4,39% | 1.497.800 |
| 12/01/2009 | 31,88 | 32,67 | 31,05 | 31,19 | -1,76% | 5,10% | 1.406.400 |
| 09/01/2009 | 32,40 | 32,68 | 31,58 | 31,75 | -3,01% | 3,41% | 744.200 |
| 08/01/2009 | 32,36 | 32,86 | 31,87 | 32,74 | -0,08% | 3,07% | 773.800 |
| 07/01/2009 | 32,46 | 32,99 | 32,01 | 32,76 | -0,64% | 3,03% | 871.400 |
| 06/01/2009 | 32,76 | 33,70 | 32,57 | 32,97 | +1,45% | 3,45% | 1.109.400 |
| 05/01/2009 | 32,12 | 32,56 | 31,49 | 32,50 | +1,39% | 3,32% | 695.600 |
| 02/01/2009 | 30,75 | 32,19 | 30,75 | 32,06 | +2,49% | 4,68% | 859.600 |
| 31/12/2008 | 31,04 | 31,52 | 30,86 | 31,28 | +1,79% | 2,13% | 904.800 |
| 30/12/2008 | 30,73 | 30,88 | 30,35 | 30,73 | +1,19% | 1,72% | 528.800 |
| 29/12/2008 | 30,85 | 30,85 | 29,90 | 30,37 | -1,25% | 3,08% | 593.600 |
| 26/12/2008 | 30,68 | 30,88 | 30,35 | 30,75 | +0,59% | 1,73% | 316.800 |
| 24/12/2008 | 30,76 | 30,78 | 30,13 | 30,57 | -0,44% | 2,11% | 292.800 |
| 23/12/2008 | 30,76 | 30,99 | 29,84 | 30,71 | -0,15% | 3,74% | 612.600 |
| 22/12/2008 | 31,62 | 31,62 | 29,88 | 30,75 | -1,91% | 5,50% | 1.100.200 |
| 19/12/2008 | 31,12 | 32,00 | 30,50 | 31,35 | -0,33% | 4,84% | 1.751.800 |
| 18/12/2008 | 30,73 | 31,93 | 30,73 | 31,46 | +3,47% | 3,91% | 1.321.800 |
| 17/12/2008 | 29,72 | 31,29 | 29,72 | 30,40 | +1,00% | 5,27% | 1.188.200 |